Cue Health PE Ratio 2020-2023 | HLTH

Current and historical p/e ratio for Cue Health (HLTH) from 2020 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Cue Health PE ratio as of May 15, 2024 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Cue Health PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2024-05-15 0.11 0.00
2023-12-31 0.16 $-2.44 0.00
2023-09-30 0.44 $-1.69 0.00
2023-06-30 0.37 $-1.83 0.00
2023-03-31 1.82 $-1.95 0.00
2022-12-31 2.07 $-1.31 0.00
2022-09-30 3.01 $-0.88 0.00
2022-06-30 3.20 $-0.30 0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.021B $0.071B
Cue Health Inc. is a health technology company. It offers individuals, enterprises, government agencies and healthcare provides access to lab-quality diagnostic testing at home, at work or at the point-of-care, all in a device. Cue Health Inc. is headquartered in San Diego.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $36.755B 20.18
Inspire Medical Systems (INSP) United States $4.712B 0.00
Axonics (AXNX) United States $3.441B 0.00
10x Genomics (TXG) United States $3.165B 0.00
IRhythm Technologies (IRTC) United States $3.092B 0.00
Hims & Hers Health (HIMS) United States $2.951B 0.00
Olink Holding AB (publ) (OLK) Sweden $2.949B 0.00
Enovis (ENOV) United States $2.880B 21.34
Azenta (AZTA) United States $2.763B 155.30
Privia Health (PRVA) United States $2.154B 120.33
Schrodinger (SDGR) United States $1.690B 0.00
Omnicell (OMCL) United States $1.391B 48.06
Phreesia (PHR) United States $1.251B 0.00
Standard BioTools (LAB) United States $0.737B 0.00
Fulgent Genetics (FLGT) United States $0.668B 0.00
Definitive Healthcare (DH) United States $0.643B 0.00
Clover Health Investments (CLOV) United States $0.505B 0.00
Talkspace (TALK) United States $0.484B 0.00
Health Catalyst (HCAT) United States $0.404B 0.00
Pulmonx (LUNG) United States $0.346B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.303B 0.00
P3 Health Partners (PIII) United States $0.212B 0.00
Butterfly Network (BFLY) United States $0.207B 0.00
Outset Medical (OM) United States $0.181B 0.00
American Well (AMWL) United States $0.148B 0.00
TruBridge (TBRG) United States $0.132B 7.10
MSP Recovery (LIFW) United States $0.113B 0.00
111 (YI) China $0.110B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.073B 0.00
Future Health ESG (FHLT) United States $0.068B 0.00
SHL Telemedicine (SHLT) Israel $0.063B 0.00
EUDA Health Holdings (EUDA) Singapore $0.057B 0.00
Augmedix (AUGX) United States $0.056B 0.00
HeartBeam (BEAT) United States $0.054B 0.00
Zepp Health (ZEPP) China $0.053B 0.00
Movano (MOVE) United States $0.041B 0.00
Akili (AKLI) United States $0.035B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.032B 0.00
CareCloud (CCLD) United States $0.030B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
Streamline Health Solutions (STRM) United States $0.020B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
Syra Health (SYRA) United States $0.011B 0.00
Biotricity (BTCY) United States $0.011B 0.00
Transgenomic (PRPO) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
HeartSciences (HSCS) United States $0.005B 0.00
Healthcare Triangle (HCTI) United States $0.004B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.001B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00